Rachel Nazarian, M.D.
NPI 1336376631 · Dermatology Physician · New York, NY
Enrolled with Medicare as Practitioner - Dermatology · source: CMS PECOS Public Provider Enrollment (2026.04.01)
Rachel Nazarian, M.D. is a Dermatology Physician provider in New York, NY (NPI 1336376631).
Provider details
- NPI number
- 1336376631
- Entity type
- Individual
- Primary specialty
- Dermatology PhysicianAllopathic & Osteopathic Physicians
- Credential
- M.D.
- Sex
- Female
- Sole proprietor
- Yes
- License
- 259325 (NY)
Specialties & taxonomies
Allopathic & Osteopathic Physicians
Profile Score
A profile completeness & documented-activity index — NOT a quality, outcomes, or patient-satisfaction rating.
- Registry tenure25% of score
17 yrs in NPPES registry
- Profile completeness25% of score
100% of core fields populated
- Practice footprint15% of score
1 documented practice location
- Medicare service volume (vs. specialty peers)25% of score
1,390 Medicare services, 2024 (ranked within specialty)
- Open Payments transparency10% of score
Has Open Payments disclosures (2024)
Medicare volume is ranked against active providers in the same specialty. Signals a provider has no public data for (e.g. Medicare claims) are left out of the score entirely — never counted as zero — so providers without that data are not penalized. See the full formula and weights in our .
What this provider does (Medicare)
Based on Medicare fee-for-service claims, 2024; not all care is captured.
| Service (HCPCS) | Medicare services | Typical Medicare-allowed (2024) |
|---|---|---|
| Destruction of Precancer Skin Growth, 2-14 Growths17003 | 591 | $7 |
| Established Patient Office Or Other Outpatient Visit With Low Level OD Decision Making, If Using Time, 20 Minutes Or More99213 | 292 | $101 |
| Destruction of Precancer Skin Growth, 1 Growth17000 | 194 | $61 |
| Biopsy of Related Skin Growth, First Growth11102 | 141 | $109 |
| Biopsy of Related Skin Growth, Each Additional Growth11103 | 34 | $57 |
| Destruction of Skin Growth, 1-14 Growths |
What this provider prescribes (Medicare Part D)
Top drugs by Medicare Part D claim volume, 2024 · 10 distinct drugs on file.
| Drug | Part D claims (2024) | Beneficiaries |
|---|---|---|
| Ketoconazole | 81 | 39 |
| Clobetasol Propionate | 44 | 28 |
| Triamcinolone Acetonide | 41 | 35 |
| Clindamycin Phosphate | 23 | 20 |
| Imiquimod | 21 | 14 |
| Mupirocin | 14 | 11 |
| Econazole Nitrate | 13 | — |
| Valacyclovir Hclbrand: Valacyclovir | 12 |
Transparency — industry payments
Based on CMS Open Payments, 2024; not all care is captured.
$4,036 across 197 records (Open Payments 2024)
Open Payments discloses payments and transfers of value (meals, travel, consulting, research, royalties) from drug and device makers to providers. This is a transparency signal, not a verdict — such payments are legal and common, and their presence is neither an endorsement nor a criticism. Source: CMS Open Payments, program year 2024.
Practice location
Mailing address
Registry dates
- Enumerated
- 2009-06-15
- Last updated
- 2013-10-08
Frequently asked questions
- What is Rachel Nazarian's NPI number?
- Rachel Nazarian's National Provider Identifier (NPI) is 1336376631, a unique 10-digit ID issued by CMS for use in standard healthcare transactions.
- What is Rachel Nazarian's specialty?
- Rachel Nazarian is listed in the NPPES registry with a primary specialty of Dermatology Physician (Allopathic & Osteopathic Physicians).
- Where is Rachel Nazarian located?
- Rachel Nazarian's practice location on file with NPPES is 35 E 35th St Rm 208, New York, NY 10016-3823.
- What is Rachel Nazarian's phone number?
- The practice phone number listed in the NPPES registry for Rachel Nazarian is (212) 684-5964.
- Does Rachel Nazarian accept Medicare?
- Rachel Nazarian is approved to bill Medicare according to CMS PECOS enrollment data (2026.04.01). Confirm current participation with the provider before scheduling.
- Is Rachel Nazarian's NPI active?
- Yes — Rachel Nazarian's NPI (1336376631) is active in the NPPES registry as of the last update on 2013-10-08.
Source: CMS NPPES Data Dissemination (June 2026). NPI Central is not affiliated with CMS. Data is provided as-is from the public registry.